BE1002114A3 - Combinaison lyophilisee ou precipitee de zwitterion de cephalosporine et de sel. - Google Patents

Combinaison lyophilisee ou precipitee de zwitterion de cephalosporine et de sel. Download PDF

Info

Publication number
BE1002114A3
BE1002114A3 BE8800015A BE8800015A BE1002114A3 BE 1002114 A3 BE1002114 A3 BE 1002114A3 BE 8800015 A BE8800015 A BE 8800015A BE 8800015 A BE8800015 A BE 8800015A BE 1002114 A3 BE1002114 A3 BE 1002114A3
Authority
BE
Belgium
Prior art keywords
salt
zwitterion
precipited
lyophilized
combination
Prior art date
Application number
BE8800015A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of BE1002114A3 publication Critical patent/BE1002114A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Composition antibiotique consistant en (a) le solide amorphe issu d'une solution aqueuse (i) du zwitterion 7-(alpha-(2-aminothiazol-4-yl)-alpha-(Z)-méthoximinoacétamido)-3-[(1-méthyl-1-pyrrolidinio)-méthyl]-3-céphème-4-carboxylate et (ii) d'un sel ou plusieurs sels dont le ou les cations sont choisis entre Na+, Li+, Ca++ et Mg++ et dont le ou les anions sont choisis entre C1-, Br- et I-, le rapport molaire zwitterion: sel total étant environ de 0,5:1 à 2:1 ou (b) ses solvates.
BE8800015A 1987-01-09 1988-01-08 Combinaison lyophilisee ou precipitee de zwitterion de cephalosporine et de sel. BE1002114A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/001,945 US4808617A (en) 1985-12-18 1987-01-09 Lyophilized or precipitated cephalosporin zwitterion and salt combination

Publications (1)

Publication Number Publication Date
BE1002114A3 true BE1002114A3 (fr) 1990-07-10

Family

ID=21698538

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8800015A BE1002114A3 (fr) 1987-01-09 1988-01-08 Combinaison lyophilisee ou precipitee de zwitterion de cephalosporine et de sel.

Country Status (33)

Country Link
US (1) US4808617A (fr)
JP (1) JP2568226B2 (fr)
KR (1) KR950010154B1 (fr)
AR (1) AR243501A1 (fr)
AT (1) AT388672B (fr)
AU (1) AU606361B2 (fr)
BE (1) BE1002114A3 (fr)
CA (1) CA1307464C (fr)
CH (1) CH676202A5 (fr)
CS (1) CS265249B2 (fr)
CY (1) CY1679A (fr)
DD (1) DD264614A5 (fr)
DE (1) DE3740588C2 (fr)
DK (1) DK166404B1 (fr)
ES (1) ES2008951A6 (fr)
FI (1) FI89006C (fr)
FR (1) FR2609396B1 (fr)
GB (1) GB2199746B (fr)
GR (1) GR871860B (fr)
HK (1) HK5593A (fr)
HU (1) HU199686B (fr)
IE (1) IE61238B1 (fr)
IL (1) IL84346A (fr)
IT (1) IT1215666B (fr)
LU (1) LU87102A1 (fr)
NL (1) NL193266C (fr)
OA (1) OA08796A (fr)
PT (1) PT86157B (fr)
SE (1) SE467910B (fr)
SG (1) SG114792G (fr)
SU (1) SU1575942A3 (fr)
YU (1) YU46689B (fr)
ZA (1) ZA88114B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
CA2011116C (fr) * 1989-03-06 1999-11-16 Murray A. Kaplan Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
WO2005094800A2 (fr) * 2004-03-31 2005-10-13 Lupin Ltd. Composition de cefepime co-precipite et procede de preparation correspondant
WO2006109324A2 (fr) * 2005-04-13 2006-10-19 Lupin Limited Procedes de preparation de sels d'addition acides de cefepime amorphes
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
EP3100732A1 (fr) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Compositions antibiotiques de ceftolozane
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
KR101935186B1 (ko) 2014-09-04 2019-01-03 시오노기세야쿠 가부시키가이샤 카테콜기를 갖는 세팔로스포린류를 함유하는 제제

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116180A (en) * 1982-03-04 1983-09-21 Bristol Myers Co Cephalosporin derivatives
FR2585705A1 (fr) * 1985-08-05 1987-02-06 Bristol Myers Co Sels de cephalosporine et compositions injectables

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953439A (en) * 1973-08-01 1976-04-27 Smithkline Corporation Substituted phenylglycylcephalosporins
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
US4406899A (en) * 1982-03-04 1983-09-27 Bristol-Myers Company Cephalosporins
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2116180A (en) * 1982-03-04 1983-09-21 Bristol Myers Co Cephalosporin derivatives
FR2585705A1 (fr) * 1985-08-05 1987-02-06 Bristol Myers Co Sels de cephalosporine et compositions injectables

Also Published As

Publication number Publication date
DK577387D0 (da) 1987-11-03
US4808617A (en) 1989-02-28
HU199686B (en) 1990-03-28
LU87102A1 (fr) 1988-08-23
NL193266B (nl) 1999-01-04
FR2609396A1 (fr) 1988-07-15
DD264614A5 (de) 1989-02-08
AT388672B (de) 1989-08-10
SE8800036L (sv) 1988-07-10
AU8085687A (en) 1989-05-11
SG114792G (en) 1992-12-24
DK577387A (da) 1988-07-10
FI89006C (fi) 1993-08-10
IL84346A (en) 1992-05-25
JPS63208522A (ja) 1988-08-30
ZA88114B (fr) 1988-06-27
YU46689B (sh) 1994-04-05
AU606361B2 (en) 1991-02-07
DE3740588C2 (de) 1996-07-11
ATA341687A (de) 1989-01-15
CH676202A5 (fr) 1990-12-28
PT86157B (pt) 1991-02-08
ES2008951A6 (es) 1989-08-16
NL8800025A (nl) 1988-08-01
AR243501A1 (es) 1993-08-31
HUT46223A (en) 1988-10-28
IT1215666B (it) 1990-02-22
IE61238B1 (en) 1994-10-19
HK5593A (en) 1993-02-05
CS15888A2 (en) 1989-01-12
KR880008811A (ko) 1988-09-13
YU2388A (en) 1989-10-31
GB8725875D0 (en) 1987-12-09
GR871860B (en) 1988-05-10
SE8800036D0 (sv) 1988-01-08
GB2199746A (en) 1988-07-20
CS265249B2 (en) 1989-10-13
FI89006B (fi) 1993-04-30
GB2199746B (en) 1990-10-24
FR2609396B1 (fr) 1993-01-29
IL84346A0 (en) 1988-04-29
FI875122A0 (fi) 1987-11-19
SU1575942A3 (ru) 1990-06-30
DK166404B1 (da) 1993-05-17
PT86157A (en) 1987-12-01
FI875122A (fi) 1988-07-10
SE467910B (sv) 1992-10-05
CA1307464C (fr) 1992-09-15
JP2568226B2 (ja) 1996-12-25
DE3740588A1 (de) 1988-07-21
OA08796A (fr) 1989-03-31
IT8819013A0 (it) 1988-01-07
CY1679A (en) 1993-10-10
KR950010154B1 (ko) 1995-09-11
IE872970L (en) 1988-07-09
NL193266C (nl) 1999-05-06

Similar Documents

Publication Publication Date Title
BE1002114A3 (fr) Combinaison lyophilisee ou precipitee de zwitterion de cephalosporine et de sel.
RO82721A (fr) Procede pour la preparation d'un antibiotique de cephalosporine
GB1526978A (en) 3-thiosubstituted cephalosporin antibiotics
FR2322790A1 (fr) Recipient pour verres de contact durs ou souples
ES8606361A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES8506025A1 (es) Un procedimiento para preparar derivados de cefem
KR870001216A (ko) 3-프로페닐 세팔로스포린 용매화물
FR2361897A1 (fr) Nouveaux derives de la cephalosporine, leurs intermediaires et procede pour les preparer
JPS5798288A (en) Novel cephem compound or its salt, their preparation, and preventive and remedy for bacteriosis containing said compound as active component
EP0319019A3 (fr) Cristaux de chlorhydrate de céphem
CS196483A2 (en) Zpusob pripravy derivatu 7beta-(z(2-)2-aminothiazol-4-yl)-2-oxyimino-acetamido)-3-cefem-4-karboxylovych kyselin
ATE40692T1 (de) Neue kristallmodifikation von ceftazidim.
IL70012A (en) 7-(1-(2-aminothiazol-4-yl)-ethene-carbonamido)-3-pyridiniummethyl-3-cephem-4-carboxylate derivatives,their preparation and antibacterial compositions containing them
ES459945A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
ES8103101A1 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
EP0238061A3 (en) Cephalosporin derivatives, processes for their preparation and antibacterial agents
JPS5214790A (en) Process for preparing cephem or penam compounds
ES8702918A1 (es) Un procedimiento para la preparacion de dihidrobromuro de acido (6r,7r)-7-((z)-2-(2-tritilaminotiazol-4-il)-2-(2-t-butiloxicarbonil-prop-2-oximino)acetamido)-3-(1piridiniometil)-3-cefem-4-carboxilico cristalino.
DE3277870D1 (en) Cephalosporin compounds
IE40206L (en) Cephalosporin derivatives
ES8501768A1 (es) Procedimiento para preparar (6r, 7r)-7-( (z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oximino)-acetamido)-3-(1-piridiniometil)-cef-3-em-carboxilato x 1, 5 moles de agua, cristalizado
GB1539053A (en) Process for the preparation of alpha-(2-oxoimidazolidinyl carbonylamino)-acetamido cephalosporins
DK536986A (da) Cephalosporinderivater, deres fremstilling og anvendelse
DE3782939T2 (de) Kristalline cephalosporinderivate.
IE33115L (en) Cephalosporins

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *BRISTOL-MYERS SQUIBB CY

Effective date: 20080108